{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:41:49Z","timestamp":1788284509759,"version":"build-2803163510"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Thyroid autoimmunity commonly coexists with type 1 diabetes due to shared autoimmune mechanisms, and early recognition of thyroid dysfunction is crucial for optimizing metabolic control. However, there is no consensus regarding the optimal screening strategy for detecting thyroid disease in patients with type 1 diabetes. This study aimed to determine the long-term predictive value of thyroid peroxidase antibodies (TPO-Abs) at the onset of type 1 diabetes for the development of thyroid dysfunction and to evaluate the influence of age at diabetes onset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective longitudinal study at a tertiary university hospital in Barcelona, Spain, including 160 Caucasian patients consecutively diagnosed with type 1 diabetes between 1987 and 1994. All participants were followed for at least 10 years (mean follow-up 30.6 \u00b1 4.5 years). TPO-Abs were measured at diabetes onset, and thyroid function was periodically assessed throughout follow-up. The incidence of thyroid dysfunction was analyzed according to TPO-Ab status and age at diabetes onset (&amp;lt;18 vs \u226518 years).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At diabetes diagnosis, 21.9% of patients were TPO-Abs positive. Antibody positivity was a strong predictor of thyroid dysfunction, conferring an eightfold increased risk compared with antibody-negative patients (RR 8.1, 95% CI 4.79\u201313.69, p&amp;lt;0.001). During follow-up, thyroid dysfunction also developed in initially antibody-negative patients, particularly in those diagnosed before 18 years of age, whereas cases were rare among those diagnosed in adulthood. The relative risk of thyroid dysfunction associated with TPO-Abs at diabetes onset was substantially higher in adults compared with youth (RR 12.6, 95% CI 6.10\u201325.81 vs. RR 3.4, 95% CI 1.35\u20138.71).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A rational screening strategy for thyroid disease in asymptomatic patients with type 1 diabetes should include measurement of TPO-Abs and thyrotropin at diagnosis, followed by annual thyrotropin assessment in antibody-positive individuals. In patients diagnosed with type 1 diabetes before 18 years of age who are initially antibody-negative, repeat screening every two years from puberty through adulthood is recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1699111","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:22:18Z","timestamp":1762147338000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Thyroid autoimmunity at onset of type 1 diabetes as a predictor of thyroid dysfunction: a thirty-years retrospective longitudinal study"],"prefix":"10.3389","volume":"16","author":[{"given":"Gemma","family":"Carreras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian C.","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Colom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Tirado-Capistros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Sard\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"S\u00e1nchez-Quesada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): national health and nutrition examination survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris","year":"2000","journal-title":"Arch Intern Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0483","article-title":"Screening for thyroid dysfunction: U.S. Preventivedoi.org services task force recommendation statement","volume":"162","author":"Michael","year":"2015","journal-title":"Ann Internal Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m41","article-title":"Thyroid disease: assessment and management","volume":"368","year":"2020","journal-title":"BMJ"},{"key":"B5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.1639","article-title":"Genetics of the autoimmune polyglandular syndrome type 3 variant","volume":"20","author":"Dittmar","year":"2010","journal-title":"Thyroid"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.02.017","article-title":"Type 1 diabetes associated autoimmunity","volume":"15","author":"Kahaly","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/dme.12318","article-title":"Thyroid autoimmunity in Type 1 diabetes: Systematic review and meta-analysis","volume":"31","author":"Shun","year":"2014","journal-title":"Diabetes Med"},{"key":"B9","article-title":"Type1 diabetes and autoimmune polyglandular syndrome: a clinical review","volume":"67","author":"Van den Driessche","year":"2009","journal-title":"Neth J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13445","article-title":"Other complications and associated conditions in children and adolescents with type 1 diabetes","volume":"23","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S004","article-title":"ADA 2025: comprehensive medical evaluation and assessment of comorbidities: standards of care 2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2002.00699.x","article-title":"Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with type 1 diabetes","volume":"19","author":"Kordonouri","year":"2002","journal-title":"Diabetes Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2004.056424","article-title":"Natural course of autoimmune thyroiditis: association with gender, age, diabetes duration and puberty","volume":"90","author":"Kordonouri","year":"2005","journal-title":"Arch Dis Child"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-2335","article-title":"Better Diabetes Diagnosis Study Group. Thyroid and islet autoantibodies predict autoimmune thyroid disease at type 1 diabetes diagnosis","volume":"102","author":"Jonsdottir","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","article-title":"Epidemiology and clinical characteristics of thyroid dysfunction in children and adolescents with type 1 diabetes","volume":"33","author":"Severinski","year":"2009","journal-title":"Coll Antropol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2595","article-title":"Thyroid Autoimmunity at onset of Type 1 Diabetes as a Predictor of Thyroid Dysfunction","volume":"30","author":"Gonzalez","year":"2007","journal-title":"Diabetes Care"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/diab.28.12.1039","article-title":"Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance","volume":"28","year":"1979","journal-title":"Diabetes"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03440110095035","article-title":"American Thyroid Association guidelines for use of laboratory tests in thyroid disorders","volume":"263","author":"Surks","year":"1990","journal-title":"JAMA"},{"key":"B19","volume-title":"National Evidence-Based Clinical Care Guidelines for Type 1 Diabetes in Children, Adolescents and Adults","author":"Craig","year":"2011"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.4.1181","article-title":"Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study","volume":"26","author":"Umpierrez","year":"2003","journal-title":"Diabetes Care"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S014","article-title":"Children and adolescents: standards of care in diabetes 2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.9.2170","article-title":"The role of autoimmunity at diagnosis of type 1 diabetes in the development of thyroid and celiac disease, and microvascular complications","volume":"28","author":"Glastras","year":"2005","journal-title":"Diabetes Care"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2472-x","article-title":"Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes","volume":"55","author":"Ziegler","year":"2012","journal-title":"Diabetologia"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.4.850","article-title":"Autoantibody \u201csubspecificity\u201d in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups","volume":"28","author":"Barker","year":"2005","journal-title":"Diabetes Care"},{"key":"B25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2337\/diacare.28.1.186","article-title":"ADA statement. Care of children and adolescents with type 1 diabetes","volume":"28","author":"Silverstein","year":"2005","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-S006","article-title":"Standards of medical care in diabetes\u20142018","volume":"41","year":"2018","journal-title":"Diabetes Care"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1699111\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:22:19Z","timestamp":1762147339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1699111\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":26,"alternative-id":["10.3389\/fendo.2025.1699111"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1699111","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"article-number":"1699111"}}